Janice A. Lukenbill
Papers
1
Total Citations
41
H-Index
1
About
Janice A. Lukenbill is a biomedical researcher whose work centers on the intersection of diabetes, renal disease, and molecular biomarkers. Her most cited study, "Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes" (2013, 41 citations), represents a significant contribution to the field of diabetic nephropathy. In this work, Lukenbill and her colleagues identified specific fragments of plasma kininogen as early, non-invasive indicators of kidney function deterioration in patients with type 1 diabetes. This finding has important implications for predicting and potentially preventing end-stage renal disease, a common and devastating complication of diabetes. By linking the kinin-kallikrein system to renal decline, her research offers a novel molecular perspective on disease progression. Though her citation count reflects a focused, high-impact contribution rather than a broad publication record, Lukenbill’s work has been recognized for its translational potential, providing a foundation for future diagnostic tools and therapeutic targets in diabetic kidney disease.
Research Focus
Key Achievements
Top Papers
- 1